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Abstract This review describes the properties of some
rare eukaryotic chaperones that each assist in the folding of
only one target protein. In particular, we describe (1) the
tubulin cofactors, (2) p47, which assists in the folding of
collagen, (3) a-hemoglobin stabilizing protein (AHSP), (4)
the adenovirus L4-100 K protein, which is a chaperone of
the major structural viral protein, hexon, and (5) HYPK,
the huntingtin-interacting protein. These various-sized
proteins (102–1,190 amino acids long) are all involved in
the folding of oligomeric polypeptides but are otherwise
functionally unique, as they each assist only one particular
client. This raises a question regarding the biosynthetic cost
of the high-level production of such chaperones. As the
clients of faithful chaperones are all abundant proteins that
are essential cellular or viral components, it is conceivable
that this necessary metabolic expenditure withstood evo-
lutionary pressure to minimize biosynthetic costs.
Nevertheless, the complexity of the folding pathways in
which these chaperones are involved results in error-prone
processes. Several human disorders associated with these
chaperones are discussed.
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Abbreviations
aa Amino acid
Ad Adenovirus
ER Endoplasmic reticulum
ERAD ER-associated degradation
Hb Hemoglobin
Pro-Pro-Gly
and Pro-Hyp-Gly
Tripeptides proline-proline-glycine
and proline-hydroxyproline-glycine
Arg, Ser Arginine, serine
Introduction
The maintenance of the three-dimensional correct protein
structure within the densely packed environment of the cell
is a prerequisite for cell survival. Tightly regulated systems
have therefore evolved to minimize protein misfolding.
Two major mechanisms protecting cells from this threat are
molecular chaperones and the ubiquitine–proteasome sys-
tem. The first facilitates correct folding while the second
removes irreversibly damaged or toxic proteins.
Molecular chaperones are a large family of cellular
proteins found in prokaryotes and eukaryotes. The term
‘molecular chaperone’ was proposed in 1978 by Laskey
and coworkers [1], who showed that misassembly during
the formation of nucleosomes in amphibian eggs could be
prevented by the inclusion of an abundant acidic nuclear
protein called nucleoplasmin. It appeared that nucleoplas-
min does not provide steric information required for
histones to bind correctly to DNA and that it is not a
component of assembled nucleosomes.
Besides being implicated in assisting correct folding
of nascent polypeptide chains and preventing protein
aggregation after cellular stress, chaperones accomplish
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important functions in cellular transport and in assembly
and disassembly of multiprotein complexes. Also, some
viruses encode chaperones while others depend on host
chaperones that are often upregulated in response to viral
infection. The diverse functions of chaperones are per-
formed through interaction with multiple target proteins
whose activity is modulated by changing their conforma-
tion and/or their localization. To accomplish these
functions, chaperones collaborate with co-chaperone part-
ners, which regulate the enzymatic activity of chaperones
and guide them to appropriate partner proteins.
Abundant and ubiquitous chaperones, which are usually
called heat-shock proteins, are able to interact with multi-
ple target proteins with diverse functions. Regulation of
their activity is quite complex. Another, more specific,
category of chaperones are the dedicated chaperones that
assist several proteins of a given class, such as proteasome-,
histone- and major histocompatibility complex (MHC)-
dedicated chaperones or fatty acid-binding proteins (FAB-
Ps); the latter are lipid chaperones directing the partitioning
of lipids inside cells. Finally, some rare chaperones assist
only one target protein. These eukaryotic chaperones, here
called faithful chaperones, are the subject of this article. The
functional uniqueness of these chaperones raises a question
of biosynthetic cost of their production. As the clients of
faithful chaperones are all abundant proteins that are
essential cellular or viral components, it is conceivable that
this necessary metabolic expenditure withstood evolution-
ary pressure to minimize biosynthetic costs.
Tubulin-specific folding cofactors
Microtubules found in all eukaryotic cells are essential for
many cellular functions, such as motility, morphogenesis,
intracellular transport, and cell division. They are a major
component of the cytoskeleton displaying highly dynamic
behavior, controlled primarily by hydrolysis of guanosine
triphosphate (GTP). Hence, factors that regulate the
microtubule cytoskeleton are critical for determination of
cell behavior and its fate. Microtubule synthesis is a
dynamic multi-step process that starts with a pool of a- and
b-tubulin subunits. The a- and b-tubulins fold in a series of
chaperone-assisted steps, where the proper folding and
assembly of tubulin a,b-heterodimers involves a stepwise
progression mediated by a group of protein cofactors, A
through E and ARL2. These cofactors act on tubulin
folding intermediates downstream of the cytosolic chap-
eronin CCT (also known as c-cpn or TriC), through a
unique combination of protein interaction domains. These
folding steps result in production of a GTP-bound tubulin
heterodimer competent for microtubule incorporation. An
a,b-tubulin dimer is a barrel-shaped basic microtubule
building block assembled in a head-to-tail arrangement,
and the asymmetry of the tubulin heterodimer is reflected
in the structure and polarity of the microtubule [2].
The preliminary step in this pathway is the binding of
newly synthesized tubulin molecules to chaperonin CCT.
Following one or more rounds of ATP hydrolysis by CCT,
the resulting quasi-native tubulin intermediates interact
with five tubulin-specific chaperones named tubulin
cofactors A through E (TBCA–TBCE). The native
assembly-competent tubulin is released from a supercom-
plex that contains both a- and b-tubulin and cofactors A–E,
and that hydrolyzes GTP as part of this reaction ([3] and
references therein); both a- and b-tubulins are GTP-binding
proteins [4]. Tubulin subunit exchange can occur only by
passage through this supercomplex, thus defining it as a
dimer-making machine (Fig. 1). Hydrolysis of GTP by
b-tubulin in the supercomplex acts as a switch for the
release of native tubulin heterodimer. These data support
a model in which the production of tubulin heterodimer via
a cofactor complex is coupled to nucleotide hydrolysis by a
small GTPase. Assembled tubulin dimers subsequently
polymerize into microtubules in a polar fashion, with
protofilaments nucleating at the microtuble-organizing
center (MTOC) and their extension occurring at the rapidly
growing (plus) end. Tubulin cofactors, originally discov-
ered as proteins required for proper tubulin folding and
heterodimer formation [5–11], have also been shown to
participate in tubulin dissociation [3, 12, 13], transitory
tubulin storage [8, 11, 14, 15], and tubulin degradation
[16–18].
The first tubulin chaperone identified in the tubulin
folding pathway was cofactor A (TBCA, 108 aa) [7, 19].
TBCA binds free native b-tubulin monomers, probably
serving as a reservoir for excess b-tubulin [5]. Rbl2p, the
TBCA ortholog in Saccharomyces cerevisiae, protects cells
from lethal b-tubulin expression by transiently binding free
b-tubulin until it forms non-toxic aggregates [15]. The
2.2 A˚ crystal structure of Rbl2p shows a-helical monomers
forming a flat, slightly convex dimer [20]. In contrast, at
1.7 A˚ resolution, the three-dimensional structure of human
TBCA showed not a dimer but a rod-like monomer, con-
sisting of a three-a-helix bundle ending on both ends with a
coiled coil, with the second helix kinked by a proline break,
offering a convex surface at one face of the protein [21].
The authors observed that the protein–protein interactions
of the TBCA are weak, which is consistent with the fact
that dimers only form under certain crystallogenesis con-
ditions, at very high protein concentrations. Peptide
mapping analysis and competition experiments with pep-
tides showed that TBCA interacts with b-tubulin via the
three a-helical regions, but not with the rod-end loops. The
crystal structure of Arabidopsis TBCA combined with
b-tubulin binding analysis confirmed the monomeric
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three-helix bundle structure and b-tubulin interaction with
the a-helical regions [22].The main interaction occurs with
the middle kinked a2 helix, at the convex face of the rod.
Strong 3D structural homology is found with the BAG
domain of Hsp70 chaperone, confirming that these proteins
belong to a family of cofactors with a simple compact
architecture. In contrast to Rbl2p that is non-essential in
yeast, TBCA is essential for cell viability in plants and
humans, and its knockdown produces a decrease in the
amount of soluble tubulin, modifications in microtubules,
G1 cell cycle arrest and cell death [8, 23].
A second cofactor, TBCB (244 aa), binds partially fol-
ded a-tubulin monomers, and a putative tubulin-binding
motif within its N-terminal domain has been identified by
sequence and structure comparison [24]. TBCB can be
nitrated, mainly on Tyr-64 and Tyr-98, and the nitration
attenuates the synthesis of new microtubules [25]. It has
been demonstrated that TBCB binding to TBCE results in
formation of a highly efficient tubulin heterodimer disso-
ciating machine, leading to a complete microtubule loss
[18]. After tubulin heterodimer dissociation, TBCB toge-
ther with TBCE and a-tubulin form a ternary complex,
while the free b-tubulin subunit is recovered by TBCA.
These complexes may serve to escort a-tubulin towards
degradation or recycling. It has been demonstrated that
growth factor-induced stimulation of p21-activated kinase
1 (Pak1) participates in the MT dynamics through the
phosphorylation of TBCB on Ser-65 and Ser-128 during
microtubule regrowth phase [26].
a-tubulin is known to be able to attach to the so called
cytoskeleton-associated protein glycine-rich (CAP-Gly)
domains that are localized at the C-terminal position in
TBCB and in the N-terminal position in TBCE [27]. The
structure of the CAP-Gly domain from the Caenorhabditis
elegans cytoskeleton-interacting F53F4.3 protein of
unknown function has been solved, revealing a novel protein
fold containing one a-helix and three b-sheets [28]. The wide
distribution of the CAP-Gly motif in cytoskeleton-associated
proteins (18 structures of Cap-Gly domains from different
proteins have been deposited by S. Yokoyama and cowork-
ers in Protein Data Bank [www.rcsb.org/pdb]), suggests that
this motif could be a common domain for attachment to
microtubules.
By a combination of modeling and structure predictions,
the presence of the ubiquitin-like (Ubl) domain was pre-
dicted at the N-terminus of TBCB [29]. This prediction was
confirmed by NMR structural analysis of the N-terminal
domain of C. elegans TBCB [24]. While its fold closely
resembles that of ubiquitin, it is unlikely that it would
function as a ubiquitin-like covalent modifier of other tar-
get proteins. Instead, the authors hypothesize that the
TBCB Ubl domain forms a scaffold for the presentation of
residues involved in protein–protein interactions, namely
between a-tubulin and TBCB or between TBCB and
TBCE.
TBCB binds partially folded a-tubulin monomers, but it
is not required for tubulin biogenesis, and is apparently not
essential in any of the studied organisms [30]. Neverthe-
less, it has been shown that TBCB, which in growing
neurites localizes at the transition zone of the growth
cones, plays a role in microtubule dynamics and in plas-
ticity during neurogenesis; TBCB knockdown enhances
Fig. 1 Schematic illustration of
the tubulin heterodimer
assembly pathway [5]. CCT
denotes cytosolic chaperonin, a
ring-like protein complex
involved in folding of tubulin
subunits. Tubulin-folding
cofactors B and E (TBCB and
TBCE) are involved in the
folding and dimerization
pathway of a-tubulin monomers
(light blue circle), while
cofactors A and D (TBCA and
TBCD) fulfil this function for
b-tubulin monomers (dark blue
circle). Note that TBCE (in
addition to TBCD) can also
dissociate tubulin dimers into
a- and b-tubulin monomers
(shown by backward directed
arrows), leading to a reduction
of the tubulin dimers pool
available for microtubules
polymerization. Modified from
[27]
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axonal growth, while TBCB overexpression leads to
microtubule depolymerization, growth cone retraction, and
axonal damage followed by neuronal degeneration [31].
The effect of TBCB on microtubule depolymerization was
also noted in plants, where overexpression of TBCB analog
reduced the number of microtubules [32]. This protein
seems to be involved in plant cell division as its knockout
caused Arabidopsis embryonic lethality [33].
TBCC (246 aa) together with cofactors D and E stim-
ulates the GTPase activity of native tubulin, a reaction
regulated by ADP-ribosylation factor-like 2 protein
(ARL2), a 21 kDa GTPase. ARL2 orthologs in yeast are
required for MT dynamics and the establishment of growth
polarity [34]. Moreover, loss of function of the ARL2
ortholog in C. elegans has been shown to cause defects in
the MT cytoskeleton as well as several developmental
defects [35]. Finally, in breast cancer cell line, modulations
of ARL2 level resulted in changes in the pool of poly-
merizable soluble tubulin heterodimers, in microtubule
dynamic instability and modifications of cell cycle pro-
gression [36]. These data confirm earlier findings that an
excess of ARL2 caused the loss of microtubules and cell
cycle arrest in the M phase [37]. However, since the ARL2
knockdown does not exhibit a distinctive phenotype, it can
be concluded that ARL2, one of the regulators of tubulin
folding and microtubule integrity, is not essential for life.
TBCD (1,190 aa) interacts with b-tubulin and contrib-
utes to the production of polymerizable tubulin
heterodimers, but it can also induce the dissociation of
soluble a,b-tubulin heterodimers [5, 11]. Overexpression of
TBCD in HeLa cells results in complete destruction of the
microtubule network [13]. This heterodimer-dissociating
activity is lost upon TBCD binding to ARL2, resulting in
enhanced a,b heterodimer concentration [12]. Genetic
experiments with Schizosaccharomyces pombe and Ara-
bidopsis thaliana have shown that TBCD is essential for
life in higher eukaryotes [38, 39]. TBCE (527 aa) is
essential for the folding of primary a-tubulin and is
required for its heterodimerization with b-tubulin; a stoi-
chiometric excess of purified TBCE dissociates tubulin
heterodimers [18]. The TBCE protein, besides the N-ter-
minal cytoskeleton-associated glycine-rich (CAP-Gly)
a-tubulin binding domain [40], contains a series of leucine-
rich repeats, which can mediate protein–protein interac-
tions [41]. Drosophila devoid of the TBCE gene are
embryonic lethal [42], demonstrating that TBCE is an
essential gene.
A novel protein has been described, called E-like (El)
because of its sequence similarity to the TBCE [16], but
which lacks the N-terminal CAP-Gly domain of TBCE
implicated in tubulin binding [27]. Despite this, upon
overexpression, E-like depolymerizes microtubules in vitro
by direct interaction with a,b heterodimers and remains
bound to a-tubulin; it commits a-tubulin to proteosomal
degradation, thereby regulating microtubule stability.
Although El apparently has no direct function in the tubulin
folding pathway, suppression of its expression results in an
increase in the number of stable microtubules and a tight
clustering of endocellular membranes around the MTOC;
on the other hand, the properties of dynamic microtubules
remain unaffected [27].
The atomic structure of TBCA and partial structure of
TBCE are known (see above). Three-dimensional models
of other TBCs have been obtained, based on the sequences
of yeast homologs of tubulin cofactors and combining
modeling and fold prediction tools [29]. These predictions,
which suggest the presence of N-terminal spectrin-like and
C-terminal RP2/CAP-like domains for TBCC and several
Armadillo repeats for TBCD, should be confirmed by
atomic structures of TBCs from higher eukaryotes. Nev-
ertheless, all these approaches suggest the presence in
TBCs of different types of domains involved in protein–
protein binding and allow the expectation of such functions
as, for example, the scaffold role of TBCC in super-com-
plex formation, which stems from structure predictions.
In view of their size and high content of protein-binding
domains, it is not surprising that some TBCs exert functions
that are independent of their role in tubulin heterodimers
folding. For example, TBCD is also a centrosomal protein
and plays a role in the organization of the mitotic spindle
[43]. It has been demonstrated that overexpression of either
the full-length protein or one of its two centrosome locali-
zation domains leads to the loss of anchoring of the gamma-
tubulin ring complex and of nucleation of microtubule
growth at centrosomes. In contrast, depletion of cofactor D
by short interfering RNA results in mitotic spindle defects
[44]. Because none of these changes in cofactor D activity
produces a change in the levels of a- or b-tubulins, it seems
that these TBCD functions are distinct from its previously
described role in tubulin folding. Furthermore, in polarized
epithelial MDCK cells, ARL2 and TBCD are involved in
disassembly of the apical junctional complex, followed by
cell dissociation from the epithelial monolayer, which is not
dependent on depolymerization of microtubules [45].
Additionally, in Trypanosoma brucei, ARL2 knockdown by
RNA interference results in a severe defect in cytokinesis
[46]. Yeast TBCE homolog, Pac2, that displays 30% iden-
tity and 54% similarity to human TBCE with conservation
of all functional domains, was shown by Voloshin and
coworkers [47] to interact with both microtubules and the
proteasome, which permitted the authors to hypothesize that
Pac2 may have a role in subcellular localization of
proteasomes.
The complexity of the folding pathway suggests that
tubulin biogenesis might be error-prone, and, indeed, sev-
eral human disorders are associated with tubulin
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chaperones. The human giant axonal neuropathy (GAN),
an autosomal recessive neurodegenerative disorder, can be
linked to faulty degradation of TBCB, resulting in its
excess [48]. As described above, TBCB forms a binary
complex with TBCE that greatly enhances its efficiency in
dissociating tubulin both in vivo and in vitro [49]. An
excess of TBCB thus leads to microtubule depolymeriza-
tion resulting in neuronal degeneration [31]. A missense
mutation in the TBCE gene was identified in mice as the
cause of progressive motor neuronopathy, associated with
irregularly structured b-tubulin, axonal swelling, severe
skeletal muscle weakness and early respiratory failure [50].
In humans, mutations/deletions of TBCE cause two
important disorders, hypoparathyroidism-retardation-dys-
morphism (HRD) and autosomal recessive Kenny-Caffey/
Sanjad-Sakati syndrome [51, 52]. Interestingly, it has been
observed that cryptic out-of-frame translational initiation
of TBCE rescues tubulin formation in heterozygous HRD,
which explains the survival of afflicted individuals, who
would otherwise lack the capacity to make functional
TBCE [53]. A hereditary eye disease, X-linked retinitis
pigmentosa, is linked to mutations in the N-terminal
domain of the RP2 gene that shares amino acid sequence
similarity with the TBCC [54, 55]. Indeed, RP2 is a
functional homolog of TBCC since it can replace the
b-tubulin GTPase stimulating activity of cofactor C in an in
vitro assay [56]. Finally, lissencephaly (agyria-pachygy-
ria), a severe developmental disease characterized by
abnormal folds on the surface of the brain and disorganized
cortical layering, can be linked to mutations in five dif-
ferent genes, including the a-tubulin gene; this last
mutation results in failure of CCT-generated folding
intermediates to stably interact with TBCB [57].
The heat shock protein 47 (Hsp47, also known
as colligin or J6 protein), collagen chaperone
Collagen is a polymer made up of three polypeptide pro-a
chains, coiled together to form a right-handed triple helix,
stabilized by a large number of Gly-Pro-X (where X rep-
resents any amino acid) repeats. Collagen fibers are the
major insoluble, fibrous component of the extracellular
matrix, endowed with remarkable tensile strength. Colla-
gen formation is a vital part of wound healing or, under
conditions of excessive collagen formation, of pathological
fibroses (for review, see [58]).
Collagen assembly begins with the folding and associ-
ation of C-terminal propeptides into trimeric assemblies
within the endoplasmic reticulum (at neutral pH). This
initial docking is aided by the formation of disulfides and is
modulated by the presence of protein-disulfide isomerase.
As a result, the proline-rich regions are close together for
efficient and accurate formation of procollagen triple helix,
which is the structure able to attach Hsp47. Trimeric pro-
collagen units with bound Hsp47 are then exported to the
extracellular space via the Golgi apparatus. Once in the
Golgi, at reduced pH the collagen trimers assemble to form
procollagen fibrils and dissociate Hsp47, which will
recycle back to the endoplasmic reticulum [59, 60]. This
chain of events is corroborated by decreased Hsp47 affinity
for collagen at lower pH [61]. At the cell surface, collagen
N-and C-propeptides are removed by the appropriate pep-
tidases, yielding the triple-helix form of mature collagen
fibrils, resistant to digestion with pepsin, trypsin or
chymotrypsin.
Throughout the synthesis and processing of collagen, the
presence of proteins such as peptidyl prolyl cis–trans-
isomerase, prolyl 4-hydroxylase and Hsp47 appears to play
a vital role assisting and/or controlling trimer assembly [62,
63]. Prolyl 4-hydroxylase functions as a chaperone inter-
acting with single-stranded procollagens, most probably
retaining premature or misfolded procollagen molecules in
the endoplasmic reticulum. Peptidyl prolyl cis–trans-
isomerases also recognize single-stranded polypeptides of
procollagens and accelerate propagation of the triple helix.
Hsp47 intervenes later in the collagen folding; it facilitates
propagation of collagen triple-helices by inhibiting thermal
denaturation of partly folded triple-helical intermediates
([64] and references therein).
Hsp47 was first isolated on a gelatin column and
described as a glycoprotein able to bind collagen IV [65].
Early observations suggested that Hsp47 binds specifically
to procollagen/collagen, interacting with different kinds of
collagen precursors such as nascent procollagen chains and
unhydroxylated non-triple helical trimers (review by Nag-
ata [66]). However, it has later been demonstrated that
Hsp47 preferentially binds fully formed helical procollagen
trimers [67], potentially stabilizing the correctly folded
collagen helix against dIssociation, before its transport
from the ER. Recently, an intriguing hypothesis has been
advanced, based on the observation that procollagen triple
helix folds spontaneously into its native conformation at
30–34C but not at body temperature, and that both pro-
collagen precursor and mature collagen are thermally
unstable at body temperature when they acquires random
coil structure [68]. Using measured triple helix folding
temperature and known binding constants, the authors
deduced that procollagen folding at 38C requires triple
helix stabilization by 45–65 kcal/mol. Thermodynamic
analysis allowed to predict that *50 lM Hsp47 will allow
procollagen folding at 38C, where over 20 Hsp47 mole-
cules have to bind to a single triple helix. It is thus
conceivable that Hsp47 assists procollagen folding by
stabilizing the triple helix. This means that the mechanism
of Hsp47 action is different from that of other chaperones,
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which preferentially bind to unfolded or misfolded
polypeptide chains before the native conformation is
achieved.
Human Hsp47 is a basic 47-kDa glycoprotein of 418
amino acids with pI close to 9. It has an N-terminal
signal sequence, that targets the molecule to the endo-
plastic reticulum (ER), and a C-terminal ER retention
signal (RDEL) [69, 70]. It is induced by heat shock,
which is unusual because all other chaperones in ER are
induced by stress due to the accumulation of unfolded
proteins. Hsp47 is constitutively expressed in collagen-
synthesizing cells, but it is not expressed in collagen-
non-producing cells [66]. Moreover, an excessive
collagen production in pathophysiological conditions is
always associated with the upregulation of Hsp47 [71].
Importantly, hsp47 gene disruption caused mortality in
embryonic mice, showing that Hsp47, indispensable for
normal procollagen biosynthesis, is essential for normal
embryogenesis in mice [72, 73]. Collagen I fibrils pro-
duced in Hsp47-null cells are abnormally thin and
branched, and undergo intracellular aggregation, which
can be prevented by transient expression of Hsp47 [74].
Thus, Hsp47 is required for prevention of formation of
procollagen aggregates in ER and is indispensable for
the formation of thick collagen fibrils. It was demon-
strated that addition of Hsp47 prevents self-association of
collagen triple helices in vitro [75]. It is possible that
Hsp47 not only facilitates triple helix formation but also
prevents lateral association of procollagen in ER. In
addition, together with several collagen mutations, a
missense mutation in the hsp47 gene is involved in the
hereditary disease in dogs, osteogenesis imperfecta [76].
Hsp47 belongs to serine protease inhibitors (serpin)
family. Serpin family members have a highly conserved
secondary structure that consists of a core of three b-sheets
surrounded by nine a-helices ([61] and references therein).
Hsp47 isolated from the membrane fraction of chick
embryos is a monomer, with composition enriched in basic
amino acids and glycine [77], while the recombinant mouse
Hsp47 was shown to exist as a mixture of two molecular
species, a monomer (*45 kDa) and a trimer (*147 kDa)
[61]; it seems though that the trimeric form is quite
insignificant [78].
The minimal Hsp47 binding site on collagen was the
subject of detailed investigations over several years.
First, when collagen fragments were used, the stretches
of non-hydroxylated Pro-Pro-Gly repeats were identified
as the major specific Hsp47 binding site [60]. However,
it appears that, in the procollagen biosynthetic pathway,
most of the Pro-Pro-Gly sequences are converted before
triple helix formation to Pro-Hyp-Gly, to which Hsp47
does not bind. Further search for Hsp47-binding
sequences, performed with synthetic collagen peptides,
identified Gly-X–Y repeats as the dominant HSP47-
binding sequences in the triple-helical procollagens, with
a requirement for a certain minimal number of Arg
residues at the position Y [79, 80]. In addition, it appears
that the arginine residue, also at the position preceding
glycine in Gly-X–Y repeats, is an additional important
structural determinant for Hsp47 binding [78]. The
importance of Arg residues is corroborated by the fact
that Hsp47 does not bind to type I and II collagens when
side chains of their arginines are modified [79]. When
the binding affinities of Hsp47 to triple-helical collagen
and a corresponding single-chain peptide were directly
compared using conformationally constrained collagen
models, Hsp47 showed a strong conformational prefer-
ence for triple-helical collagens, which confirms that
Hsp47 is unlikely to be involved in events preceding the
triple helix formation [78].
Misfolded procollagens in Hsp47-/-cells were
degraded in the lysosomes via an autophagic pathway
[81]. An interesting question is how the accumulation of
aggregation-prone misfolded proteins within the ER
triggers autophagy, which is an exclusively cytoplasmic
phenomenon. It appears that ER stress may be an
important inducer of autophagic degradation of ER pro-
teins, including aggregated procollagen. Data provided
by Ishida and coworkers [81] suggest that there exists
some mechanism to discriminate among misfolded pro-
teins in the ER and determine their processing either by
ERAD or autophagy. The molecular conformation of the
misfolded protein may determine which degradation
pathway is used.
Multiple observations demonstrated that Hsp47 is
implicated in molecular maturation of type I and type III
collagens, the most prevalent matrix proteins that are
involved in formation of fibrotic tissue. Accumulation of
fibrotic tissue destroys the normal structure of tissues,
resulting, ultimately, in end-stage organ failure. A series of
reports have indicated that Hsp47 is identified as an auto-
antigen in the sera of several rheumatoid arthritis (RA),
pulmonary fibroses, systemic sclerosis, and mixed con-
nective tissue disease patients [82] and references therein).
Interestingly, Hsp47 has been shown to be upregulated in
all studied fibrotic diseases (reference in [83]). Accord-
ingly, the administration of antisense oligonucleotides
against Hsp47 was reported to suppress the accumulation
of collagen in a renal disease, the tubulointerstitial fibrosis
[84], in peritoneal fibrosis [85] and wound-associated
scarring [86]. Another fibrotic disease, liver cirrhosis,
could be almost completely resolved by delivery of Hsp47
siRNA to cirrhosis rat model [87]. Also, several low
molecular weight compounds were found to inhibit the role
of Hsp47 in accumulation of fibrotic tissue in vitro and in
vivo [88, 89].
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Adenovirus 100 K protein, a hexon chaperone
Protein 100 K is a late adenovirus (Ad) polypeptide
encoded by the L4 transcription unit and produced in large
amounts during virus infection [90]. Depending on the Ad
serotype, L4-100 K contains 628–984 amino acid residues,
with 805 residues for Ad2 and Ad5, the most frequently
studied serotypes. L4-100 K is the first protein translated
with the onset of the late phase of infection [91]. However,
despite large production, L4-100 K, unlike other late pro-
teins, is not a structural protein––and is not found in mature
virions [92]. L4-100 K plays a vital role in the late phase of
Ad life cycle, where it is engaged in multiple processes,
such as alteration of cellular machinery in favor of trans-
lating large amounts of late virus products, involvement in
nuclear accumulation necessary for capsid assembly,
chaperoning hexon for trimerization and its nuclear trans-
port, acting as a scaffold in the intranuclear assembly of Ad
virions and, finally, preventing apoptosis of infected cells.
L4-100 K of Ad2, a native protein from infected human
cells as well as the recombinant protein obtained in insect
cells, migrates at 100 kDa, with a minor species/band at
approximately 98 kDa, resulting from some proteolytic
cleavage of the primary gene product [93, 94]. Sucrose
density gradient analysis suggested a monomeric status of
this chaperone [94, 95]. Nevertheless, some observations
suggest that L4-100 K might be able to dimerize [96].
Based on sequence homology among several adenovirus
subgenera, the L4-100 K protein can be divided into three
regions: an N-terminal region (NTR) of up to 170
amino acids, a central conserved region (CCR) of 600–700
amino acids and a C-terminal region (CTR) of 20–100
amino acids (Fig. 2) [97]. An analysis of structural features
of human Ad2 L4-100 K performed by [98] revealed two
distinct potential RNA binding motifs: RNA recognition
motif (RRM) located between positions 348 and 466,
described by Hayes and coworkers [99], and an arginine-
glycine-glycine (RGG)-rich RNA binding motif (RGG
box) located between positions 727 and 764, containing
three RGG repeats and four glycine-arginine-rich (GAR)
sequences. RGG box can also function as a nuclear local-
ization signal (NLS), which is more precisely localized
within the GAR sequence between positions 749 and 773
[100]. In addition, there is a 10-amino acid sequence in the
L4-100 K protein located between residues 383 and 392
and similar to Rev-like nuclear export signal (NES) [101,
102]. Analysis of the L4-100 K amino acid sequences for
known protein–protein interaction domains also revealed
three potential coiled-coil regions.
L4-100 K chaperone role in Ad hexon trimerization and
its nuclear transport has been studied extensively [90, 94,
103, 104]. A client protein of L4-100 K, the hexon, is a
major capsid protein of Ad virion present in 240 copies and
forming the 20 facets of the viral icosahedron. Each hexon
capsomer is trimer of three identical monomers/polypep-
tides with molecular weights of 110–120 kDa, depending
on Ad serotype. These monomers are associated into tri-
mers. The crystallographic structure of Ad2 hexon revealed
the trimeric protein as a pseudo-hexagonal base with a
triangular top, where the monomers are composed of two
eight-stranded b-barrels and four extended loops [105,
106]. Stable complexes of 600–800 kDa containing the
L4-100 K protein and the hexon monomer were detected in
Ad-infected cells by immunoprecipitation [104, 107, 108]
and were isolated by gel-filtration chromatography [104,
109]. In addition, a scaffolding role of L4-100 K protein in
the intranuclear assembly pathway of Ad virions has been
suggested on the basis of phenotypic analysis of tempera-
ture-sensitive mutants of the protein [93].
Initial data on the role of L4-100 K in hexon biogenesis
in mammalian cells were confirmed by studies performed
in a heterologous eukaryotic system. When expressed alone
from recombinant baculovirus, hexon polypeptide was
found to be insoluble and accumulated as inclusion bodies
in the cytoplasm; a proper folding of hexon into trimers
occurred only upon co-expression with L4-100 K protein
[94]. EM analysis revealed that recombinant hexons
recovered from insect cells have morphological charac-
teristics of native hexon capsomers. The results obtained in
the heterologous system implied that no other adenoviral
proteins than L4-100 K were required to achieve hexon
trimerization and showed that L4-100 K role cannot be
fulfilled by insect cell chaperones. Thus, the presence of
L4-100 K protein represents the necessary and sufficient
condition for hexon trimer formation.
EM observation of purified recombinant Ad2 L4-100 K
and native L4-100 K protein from Ad5-infected 293 cells
showed a nearly symmetrical, dumbbell-shaped molecule
consisting of two globular domains, joined by a rod-like
structure (Fig. 3). The overall volume of the molecule
allowed calculation of an estimated molecular mass
compatible with that of a monomeric L4-100 K protein
[94].
Fig. 2 Structural regions identified within the adenovirus L4-100 K
protein: coiled-coil region (CCR, aa 439–458), RNA recognition
motif (RRM, aa 383–458), Rev-like nuclear export signal (NES, aa
383–392), arginine-arginine-glycine (RGG) box (aa 727–743), con-
taining three RGG motifs and overlapping nuclear localization signal
(NLS, aa 727–764) (from [98])
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Results obtained with the L4-100 K ts-mutants main-
tained at the nonpermissive temperature showed that hexon
accumulated in the cytoplasm and failed to be transported
to the nucleus [92, 110]. The role of L4-100 K in nuclear
transport was therefore postulated. This, combined with the
inability to detect trimers in the cytoplasm, led to the
hypothesis that hexon protein trimerizes in the nucleus.
This constitutes a rather unlikely scenario in the light of
results obtained by Hong and coworkers [94]. These novel
biochemical data and microscopic observations suggest
that within the cytoplasm the L4-100 K interacts with both
hexon monomers and trimers, whereas in the nucleus it is
found exclusively in complexes with hexon trimers. The
authors postulated that within the cytoplasm hexon
monomers are assisted by the L4-100 K chaperone protein
in their folding into trimers and, subsequently, only the
complexes of L4-100 K protein with hexon trimer (but not
monomer) are transferred to the nucleus. In these experi-
ments, only hexon and L4-100 K genes were delivered to
the insect cells by the recombinant baculovirus, and these
data together with earlier studies prove that L4-100 K is a
chaperone for hexon trimerization and nuclear transport. It
was proposed that another viral protein, pVI, that shuttles
between the nucleus and the cytoplasm, is implicated in the
nuclear import of hexons [111, 112]. It is conceivable that
at different stages of Ad life-cycle nuclear import of hexon
could be mediated by two different partners.
Interaction domains in L4-100 K protein and on hexon
have not yet been precisely identified. EM images of 100 K
protein–hexon trimer complexes suggests that the chap-
eron–hexon interaction occurred via one of the globular
domains of the L4-100 K molecule with either the distal or
the apical domain of the hexon capsomer (Fig. 3) [94].
Since the atomic structure of the chaperone is not available,
it is difficult to identify the domains/regions of L4-100 K
polypeptide involved in the contacts. Our data from bio-
chemical analyses of hexon intaraction with L4-100 K
deletion mutants suggest that both N- and C-terminal
domains of L4-100 K are involved in hexon binding
(unpublished results). Furthermore, L4-100 K protein–
hexon interaction is not serotype-specific since the
L4-100 K from Ad2 (subgroup C) assisted not only in the
trimerization of hexons from serotypes belonging to the
same subgroup (e.g., Ad5) but also to a different one,
subgroup B, (e.g., Ad3) [94]. This suggests that the 100 K
protein regions involved in hexon folding are functionally
conserved, at least between chaperones from subgroups B
and C adenoviruses.
Another important function of L4-100 K is prevention
of cellular mRNA translation through elimination of the
cap (m7G)-dependent translation pathway and promoting
viral mRNA translation [96, 98, 99, 113–117]. Underlying
these processes is the interaction of L4-100 K with the
scaffolding element of the translation initiation complex,
namely, eukaryotic initiation factor G (eIF4G). The
L4-100 K binds by its N-terminal part to the C-terminus of
eIF4G, near or at the place occupied by Mnk1 protein
kinase, which is responsible for phosphorylation of the
Fig. 3 Visualisation of Ad L4-100 K protein alone and in the
complex with hexon. a Gallery of eight EM images of the
recombinant Ad2 L4-100 K protein, the averaged image, and the
structural model of the L4-100 K protein (from left to right, upper
panel). The L4-100 K protein is a dumbbell-shaped molecule,
consisting of two globular domains linked by a rod-like structure.
The total length of the molecule is about 120 A˚. b Gallery, the
averaged image and the model of the recombinant Ad3 hexon-Ad2
L4-100 K protein complex, with the hexon in end-on view (from left
to right, lower panel). One of the globular domains of the L4-100 K
protein is attached either to the distal domain or to the apical domain
of the hexon trimer. c EM analysis of native proteins purified from
Ad5-infected 293 cells. Scale bar 30 nm. Most of the visible
structures are hexons. Some L4-100 K protein molecules and
hexon–100 K protein complexes are marked with black and white
arrows, respectively. The column on the right represents five images
of hexon–100 K protein complexes and five images of 100 K protein
molecules (upper and lower columns, respectively) (from [94])
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cap-binding protein eIF4E. Competitive displacement of
Mnk1 results in dephosphorylation of eIF4E leading to
inhibition of cap-dependent cellular mRNA translation [98,
114]. An eIF4G-binding element, which is critical for
inhibition of host-cell protein synthesis, is localized in the
N-terminal region of the L4-100 K protein (positions
280–345) (Fig. 2).
Interestingly, late Ad messenger RNAs are capped, but
are translated despite the inhibition of cap-dependent cel-
lular protein synthesis by L4-100 K (see above). This is
due to the presence in the viral mRNAs of 50 noncoding
region (50NCR), also called the tripartite leader. During late
viral infection, L4-100 K, through its RNA-binding ele-
ment located in the middle region (but not through RGG
RNA-binding domain, present in the C-terminal part)
together with the cap initiation complex recruits with
higher specificity mRNAs that contain the tripartite leader
50NCR [96, 115]. The L4-100 K-tripartite leader complex
enhances association with the initiation factor 4G (eIF4G)
and poly(A) binding protein, which is accompanied by
increased translation through ribosome shunting. The
ribosome shunting is a form of translation initiation, in
which 40S ribosome subunits are directed by the tripartite
leader to the downstream initiating codon in a nonlinear
manner, bypassing intervening RNA regions [96, 115–
118]. These data emphasize the multifunctionality of
L4-100 K protein, which, by N-terminal part interaction
with eIF4G, prevents eIF4E phosphorylation thus inhibit-
ing cap-dependent translation of host messengers, while
using its RNA-binding middle region it promotes recruit-
ment of tripartite leader-containing viral messengers to
ribosomes, thereby promoting cap-dependent translation of
viral messengers.
The L4-100 K protein is also involved in modulation of
host immune response to viral infection, in which cytotoxic
lymphocytes are the main players. Andrade and coworkers
have shown that L4-100 K is a substrate of Granzymes––B
(GrB) and H (GrH)––cellular proteases present in granules
of cytotoxic lymphocytes, while at the same time it is a
potent and specific inhibitor of human GrB [97, 119, 120].
This inhibition prevents GrB-induced apoptosis of
Ad-infected cells so that the virus can complete its life
cycle. Differently from GrB, GrH is not inhibited by
L4-100 K [120]. Instead, it cleaves L4-100 K which
decreases the inhibitory efficacy of L4-100 K and allows
the recovery of GrB activity.
Biochemical analysis demonstrated that the specificity
of the Ad5 L4-100 K protein for human GrB resides in two
distinct regions of L4-100 K. It is proposed that Ad5
L4-100 K first attaches to the GrB active site through its
IEQD48;P49 sequence. The initial complex between the
protease and L4-100 K is stabilized by interaction of the
C-terminal 688–781 (CT688-781) fragment of L4-100 K
with the GrB sequence outside the enzyme catalytic site
(exosite), which has not been precisely localized [97]. Ad5
L4-100 K inhibitory activity is uniquely directed against
the human protease and does not affect the mouse and rat
orthologs, despite the degree of sequence homology among
GrBs. Although the L4-100 K protein sequence is well
conserved among different adenovirus subgenera, no
homology is observed at the amino- and carboxy-terminal
extremes. Therefore, the N-terminal region containing the
motif essential for human GrB inhibition is unique for the
Ad5 L4-100 K. Additionally, CT688-781 in L4-100 K
interacts with human GrB exosite, but not with that of
mouse or rat. Stable binding and efficient inhibition of GrB
is dependent on Asp-48 in L4-100 K. The D48A L4-100 K
mutant that is not active in GrB inhibition is nevertheless
functional in other viral pathways, which suggests that
GrB inhibitory effect evolved independently from other
L4-100 K functions [119].
Multiple functions and interactions of L4-100 K are
regulated by its posttranslational modifications including
phosphorylation and methylation. The tyrosine phosphor-
ylation, which has no influence on interaction with the
initiation factor 4G, importantly enhances preferential
binding of L4-100 K protein to tripartite leader mRNAs;
mutations of tyrosine 365 and/or 682 were sufficient to
abolish L4-100 K protein preferential binding to mRNA
tripartite leader essential for promoting ribosome shunting
[96]. It was recently shown that methylation of arginine
located in the RGG domain regulates the L4-100 K binding
to hexon and promotes the capsid assembly in the nucleus
[100].
The importance of L4-100 K for the Ad life cycle was
confirmed by the phenotype of L4-100 K deleted Ad5
vectors, produced in the L4-100 K-complementing K-16
cell line. Such recombinant adenoviruses were prepared for
gene therapy applications with the aim to overcome the
unwanted toxicity associated with Ad late gene expression.
After infection of non-complementing cells, those vectors,
as could be expected, had a significantly decreased ability
to express several Ad late genes and were blocked in their
ability to produce infectious virions. Such properties and
decreased hepatotoxicity observed after in vivo adminis-
tration suggest that the L4-100 K deletion strategy may be
useful in preparation of safer Ad vectors for gene therapy
application [121].
The a-hemoglobin-stabilizing protein (AHSP),
also known as EDRF (erythroid differentiation related
factor) and ERAF (erythroid associated factor)
Mammalian hemoglobin A (HbA) is a tetramer of two
a- and two b-globin chains. It is crucial to erythrocyte
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formation that the two globin chains be produced at bal-
anced levels since any disruptions resulting in an excess of
either chain have significant, deleterious effects on red cell
survival, a situation most clearly illustrated by important
human diseases, such as thalassemias [122]. In addition,
free a-Hb (a-globin plus heme, or holo-a-globin) is a potent
oxidant, catalyzing the production of reactive oxygen
species (ROSs), which damage erythroid precursors and
mature erythrocytes [123].
Using a screen for genes induced by the essential ery-
throid transcription factor GATA-1, Kihm and coworkers
[124] identified the AHSP protein (102 aa) that stabilizes
free a-hemoglobin. AHSP mRNA is expressed exclusively
in hematopoietic tissues including bone marrow, spleen
and fetal liver. AHSP is an abundant, erythroid-specific
protein that forms a stable heterodimeric complex with free
a-hemoglobin. Although AHSP is able to interact with
multiple forms of a-globin, including apo-, ferrous and
ferric states bound to a variety of ligands, it does not
interact with b-hemoglobin or HbA (a(2)b(2)). Moreover,
AHSP specifically protects free a-hemoglobin from pre-
cipitation both in vitro and in live cells, and reduces
oxidant-induced precipitation of a-globin in solution [124,
125]. Finally, AHSP promotes refolding of denatured
a-globin and HbA assembly from newly synthesized
a-globin in vitro [126].
Gene ablation studies in mice demonstrated that AHSP
is required for normal erythropoiesis. AHSP (-/-)
homozygous knockout mice exhibit mild hemolytic ane-
mia, shortened erythrocyte lifespan and high levels of
reactive oxygen species, consistent with the presence of
unstable a-globin [124]. AHSP-null erythrocytes are short-
lived, contain Hb precipitates, and exhibit signs of oxida-
tive damage. Predictably, loss of AHSP exacerbates
b-thalassemia in mice and results in increased a-globin
precipitation, suggesting that altered AHSP expression or
function could modify thalassemia phenotypes in humans
[124, 127]. Recently, the first mutant of AHSP,
AHSP(V56G), was discovered associated with clinical
symptoms of mild thalassemia [128]. The kinetics analysis
showed that the AHSP(V56G) apparently does not bind
long enough (0.5 vs. 2 s for the WT) to stabilize a-globin.
Biophysical characterization demonstrated that mono-
meric AHSP in solution forms a moderate affinity complex
with a-globin with 1:1 stoichiometry and with an associa-
tion constant of 1 9 107 M-1 [129]. A far-UV circular
dichroism spectrum showed that slightly elongated AHSP
is primarily a-helical in conformation, probably with an
extended C-terminal region. The crystal structure of AHSP
bound to Fe(II)-aHb revealed that AHSP binds a-globin at
the a1b1 dimer interface, opposite the heme binding
pocket, where it is easily displaced by attachment of
b-globin [125]. The structure of AHSP bound to ferrous
aHb is thought to represent a transitional complex through
which aHb is converted to a non-reactive, hexacoordinate
ferric form. The crystal structure of this ferric a-Hb-AHSP
complex at 2.4 A˚ resolution revealed a striking bis-histi-
dine configuration, in which both the proximal and the
distal histidines of a-Hb coordinate the heme iron atom. To
attain this unusual conformation, segments of a-Hb
undergo drastic structural rearrangements, including the
repositioning of several a-helices. Moreover, conversion to
the ferric bis-histidine configuration strongly and specifi-
cally inhibits redox chemistry catalysis and heme loss from
a-Hb. The observed structural changes, which impair the
chemical reactivity of heme iron, explain how AHSP sta-
bilizes a-Hb and prevents its damaging effects in cells
[130]. Taken together, X-ray crystallography, NMR spec-
troscopy, and mutagenesis data indicate the importance of
an evolutionarily conserved proline, Pro-30, in loop 1 of
AHSP. In complex with aHb, AHSP Pro-30 adopts a cis-
peptidyl conformation and establishes contact with the
N-terminus of helix G in a-Hb. As described above,
complex formation suppresses the heme-catalyzed evolu-
tion of reactive oxygen species by converting a-Hb to a
conformation in which the heme is coordinated at both
axial positions by histidine side chains (bis-histidine
coordination). Mutations that stabilize the cis-peptidyl
conformation of free AHSP also enhance the conversion
of a-Hb. These findings suggest that AHSP loop 1 can
transmit structural changes to the heme pocket of a-Hb
[131].
Since AHSP and b-Hb have overlapping binding sites
on aHb, the addition of b-Hb to either Fe(II)- or Fe(III)
aHb.AHSP displaces AHSP to generate tetrameric
(a(2)b(2)) HbA species. These findings suggest a bio-
chemical pathway through which AHSP might participate
in normal Hb synthesis and modulate the severity of tha-
lassemias. Indeed, some thalassemia phenotypes could be
explained by a decreased expression of the Ahsp gene
[132], or by an a-Hb variant displaying an impaired
interaction with the AHSP or partner b chain [133], thereby
hampering formation of a a1b1 dimer [134, 135]. Recently,
in a murine model of b(IVS-2-654)-thalassemia, the
expression of wt AHSP was able to improve the anemia
phenotype and partially relieve this thalassemia syndrome
[48], suggesting a possible role for AHSP in the treatments
of thalassemia.
HYPK, the Huntingtin-interacting protein
HYPK is one of 13 Huntingtin-interacting proteins isolated
by double hybrid technique [136], but possibly the only one
with chaperone activity. HYPK (NP_057484) shares no
significant sequence homology with any protein of known
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sequence/structure in the databases. It is not found in yeast.
It is a small protein with theoretical molecular weight of
14,665 and theoretical pI of 4.9 [137]. HYPK is an
intrinsically unstructured protein with an endoplasmic
reticulum retention signal (Fig. 4). Indeed, the protein is
significantly enriched in glutamate (15.89%), lysine
(6.62%), arginine (8.61%) and other charged amino acids,
and depleted in tryptophan, phenylalanine, and cysteine,
order-promoting residues.
The partner of HYPK, Huntingtin protein (Htt), an
approximately 350-kDa protein of unknown function, is
implicated in Huntington disease (HD), an autosomal
dominant neurodegenerative disease characterized by loss
of striatal neurons. The neuropathology of HD is thought to
be due to elongation of a polyglutamine segment (poly Q)
in Htt N-terminal extremity. HYPK was found to reduce
Htt polyglutamine aggregation upon overexpression; it
interacts physically with the N-terminal extremity of Htt
and alters the numbers and distribution of aggregates [138].
The aggregates formed by the mutated N-terminal Htt lead
to enhanced apoptosis [139], and overexpression of HYPK
reduces apoptosis based on poly Q-mediated activation of
caspase-2, caspase-3 and caspase-8.
The seminal study of Raychaudhuri and collaborators
[138] demonstrated that HYPK is a chaperone. Recombi-
nant HYPK reduced temperature-induced aggregation of
alcohol dehydrogenase and malate dehydrogenase in a dose
(concentration of HYPK)-dependent manner. Also, rena-
turation kinetics of unfolded bovine carbonic anhydrase
(BCA) was accelerated significantly in the presence of
HYPK. Furthermore, when HeLa cells expressing heat-
sensitive luciferase protein and transfected with
GFP-HYPK underwent heat shock at 45C for 30 min,
luciferase activity was *15-fold higher in the presence of
HYPK, indicating a significant increase in properly folded
luciferase. These results showed unequivocally that HYPK
exhibits chaperone-like activity. HYPK does not have any
sequence homology to known chaperones but it has been
found linked with ribosome-associated chaperone complex
containing MPP11 and Hsp70L1 (homologues of Hsp40
and Hsp70) [139]. The structural basis of recognition by
HYPK of oligomeric structures in the form of poly Q is not
yet known. In addition, it was recently shown that oxida-
tion-dependent oligomers of Htt form spontaneously in cell
and mouse HD models [140, 141]. The role of these
oligomers in HT is not clear, and nothing is as yet known
on the eventual role of HYPK in their life cycle.
It seems that HYPK might have roles beyond prevention
of Htt aggregation. Endogenous HeLa cells HYPK was
found to be a cytosolic partner of the N-terminal-acetyl-
transferase complex responsible for Na-terminal
acetylation, the most common protein modifications in
eukaryotes [142]. HYPK appeared to be required for
N-terminal acetylation of some substrates and for cell
survival. Indeed, HYPK knockdown resulted in HeLa cell
death and accumulation of cells in the G1/G0 phase.
Concluding remarks
The mechanism of protein folding in the cell remains one
of the central problems in biology. It is an extremely active
field of research, including some aspects of biology,
chemistry, biochemistry, computer science and physics.
Folding of newly synthesized polypeptides in the crowded
cellular environment requires the assistance of so-called
molecular chaperones. Chaperones are defined as a group
of proteins that assist in non-covalent folding and unfold-
ing, and assembly and disassembly of macromolecular
structures, but are not permanent components of these
structures during their performance of normal biological
functions [143]. Through their remarkable ability to
distinguish between native and non-native protein struc-
tures, molecular chaperones participate in a variety of
cellular processes that depend critically on the conforma-
tion of the proteins involved.
The vast majority of chaperone research concerns their
role in protein folding, whereas much less is known about
their function in the assembly of oligomeric complexes.
We were interested in a subgroup consisting of five
eukaryotic molecular chaperones that assists not only in
folding but also in assembly of oligomeric polypeptides.
As each of these chaperones assists only one client, it
raises the question regarding the biosynthetic cost of the
high-level production of such chaperones. The clients of
faithful chaperones are all abundant proteins that are
essential cellular or viral components; it is thus conceiv-
able that this necessary metabolic expenditure withstood
evolutionary pressure to minimize biosynthetic costs.
Future work will be necessary to provide a better
understanding of unexplored facets of these and poten-
tially other chaperone activities, such as their
thermodynamics and the mechanism of recognition of a
particular client, all based on observation of protein
movement and interactions in individual living cells. This
knowledge is important for understanding the efficiency
of chaperone action and is also necessary for productive
therapeutic interventions.
1 6   22 26 35 69  111  129 
Acidic SH3-binding coiled coil
Fig. 4 Schematic model of the predicted domains of HYPK chap-
erone, a Huntingtin-interacting protein. Domains are shown from left
to right: acidic, putative SH3-binding and coiled coil (after [142])
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